Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers Essential Hypertension

In brief

Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.

Key facts

Study ID

NCT06823947

Run by

Kyowa Kirin Co., Ltd.

People needed

160

Starts

2025-04-03

Expected to finish

2027-12-01

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

Where it is running

• Kitasato University Kitasato Institute Hospital — Minato-ku, Tokyo, Japan (enrolling)
• SOUSEIKAI PS Clinic — Hakata, Fukuoka, Japan
• Medical Corporation Heishinkai OPHAC Hospital — Yodogawa, Osaka, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.